Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Urinary miRNAs as Diagnostic Biomarkers for Prostatic Cancer: Current Dilemmas and Novel Potential Role for a Digital Rectal Examination

Author(s): Ilias Giannakodimos*

Volume 29, Issue 25, 2022

Published on: 07 March, 2022

Page: [4311 - 4313] Pages: 3

DOI: 10.2174/0929867329666220118101733

« Previous Next »
[1]
Payne, H.; Cornford, P. Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer. Urol. Oncol., 2011, 29(6), 593-601.
[http://dx.doi.org/10.1016/j.urolonc.2009.11.003] [PMID: 20060331]
[2]
Roehrborn, C.G. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia. Int. J. Impot. Res., 2008, 20(Suppl. 3), S19-S26.
[http://dx.doi.org/10.1038/ijir.2008.53] [PMID: 19002120]
[3]
Paiva, R.M.; Zauli, D.A.G.; Neto, B.S.; Brum, I.S. Urinary microRNAs expression in prostate cancer diagnosis: A systematic review. Clin. Transl. Oncol., 2020, 22(11), 2061-2073.
[http://dx.doi.org/10.1007/s12094-020-02349-z] [PMID: 32323148]
[4]
Wahid, F.; Shehzad, A.; Khan, T.; Kim, Y.Y. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta, 2010, 1803(11), 1231-1243.
[http://dx.doi.org/10.1016/j.bbamcr.2010.06.013] [PMID: 20619301]
[5]
Balacescu, O.; Dumitrescu, R.G.; Marian, C. MicroRNAs role in prostate cancer. Methods Mol. Biol., 2018, 1856, 103-117.
[http://dx.doi.org/10.1007/978-1-4939-8751-1_6] [PMID: 30178248]
[6]
Li, Z.; Li, L.X.; Diao, Y.J.; Wang, J.; Ye, Y.; Hao, X.K. Identification of urinary exosomal miRNAs for the non-invasive diagnosis of prostate cancer. Cancer Manag. Res., 2021, 13, 25-35.
[http://dx.doi.org/10.2147/CMAR.S272140] [PMID: 33442291]
[7]
Pritchard, C.C.; Cheng, H.H.; Tewari, M. MicroRNA profiling: Approaches and considerations. Nat. Rev. Genet., 2012, 13(5), 358-369.
[http://dx.doi.org/10.1038/nrg3198] [PMID: 22510765]
[8]
Mekhail, S.M.; Yousef, P.G.; Jackinsky, S.W.; Pasic, M.; Yousef, G.M. miRNA in prostate cancer: New prospects for old challenges. EJIFCC, 2014, 25(1), 79-98.
[PMID: 27683458]
[9]
Landers, K.A.; Burger, M.J.; Tebay, M.A.; Purdie, D.M.; Scells, B.; Samaratunga, H.; Lavin, M.F.; Gardiner, R.A. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int. J. Cancer, 2005, 114(6), 950-956.
[http://dx.doi.org/10.1002/ijc.20760] [PMID: 15609297]
[10]
Etzioni, R.; Kooperberg, C.; Pepe, M.; Smith, R.; Gann, P.H. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics, 2003, 4(4), 523-538.
[http://dx.doi.org/10.1093/biostatistics/4.4.523] [PMID: 14557109]
[11]
Rigau, M.; Olivan, M.; Garcia, M.; Sequeiros, T.; Montes, M.; Colás, E.; Llauradó, M.; Planas, J.; Torres, Id.; Morote, J.; Cooper, C.; Reventós, J.; Clark, J.; Doll, A. The present and future of prostate cancer urine biomarkers. Int. J. Mol. Sci., 2013, 14(6), 12620-12649.
[http://dx.doi.org/10.3390/ijms140612620] [PMID: 23774836]
[12]
Otto, J.J.; Correll, V.L.; Engstroem, H.A.; Hitefield, N.L.; Main, B.P.; Albracht, B.; Johnson-Pais, T.; Yang, L.F.; Liss, M.; Boutros, P.C.; Kislinger, T.; Leach, R.J.; Semmes, O.J.; Nyalwidhe, J.O. Targeted mass spectrometry of a clinically relevant PSA variant from post-DRE urines for quantitation and genotype determination. Proteomics Clin. Appl., 2020, 14(6), e2000012.
[http://dx.doi.org/10.1002/prca.202000012] [PMID: 32614141]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy